By measuring the activity of four genes in cancer cells, scientists at Albert Einstein College of Medicine accurately predicted whether colorectal tumors are sensitive or resistant to 5-Fluorouracil (5-FU), an important chemotherapy drug.
On Purim, over 60 Yeshiva University students helped spread the holiday festivities to fellow Jews by participating in the annual Simcha Deliveries program. Dressed in costume, the young men and women visited patients, sang, and delivered mishloach manot, traditional holiday gifts of food, to eight different hospitals and nursing homes around Manhattan and the Bronx.
Researchers at the Albert Einstein College of Medicine of Yeshiva University have discovered a genetic signature identifying cases of lymphoma that are uniquely susceptible to a newly developed molecular targeted therapy. As a result, physicians organizing clinical trials of the new therapy will be able to enroll patients who’ll be most likely to benefit from it.
Researchers at the Albert Einstein College of Medicine of Yeshiva University and its Manhattan hospital affiliate, Beth Israel Medical Center, have found that a specific mutation in a single gene is a major cause of Parkinson’s disease among Ashkenazi (Eastern European) Jews. The report will appear in the January 26 issue of The New England Journal of Medicine.
More than 130 Yeshiva University students in costume fanned out to 10 hospitals and nursing homes in Manhattan and The Bronx and delivered 350 baskets to patients to help them celebrate the festive holiday of Purim on Sunday, March 7.